Funding for acquisition of MCM and pandemic influenza preparedness and response under new solicitation HHS-barda-11-100-SOL-00020 (company c)
Ended Awarded Last action
- Contract number
- HHSO10033001T
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $4,002,243
Award facts
- Opportunity
-
- 11100SOL00020 Solicitation number
- Acquisition of MCMs for Pandemic Influenza Preparedness and Response Award Notice · Posted Jan 31, 2012
- Contract value 100% obligated
- $4,002,243.15 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$12,688 | |
| Funding Only Action | $1,716,136 | |
| Other Administrative Action | $754,779 | |
| Original award | $1,544,016 |
About this award
This federal contract award provides $4,002,243.15 in funding to Glaxosmithkline, LLC, a pharmaceutical company, for the acquisition of medical countermeasures (MCMs) and pandemic influenza preparedness and response under a new solicitation from the Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS-BARDA). The contract is a delivery order issued under the Pandemic Influenza Preparedness and Response 2012-2016 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. It is a firm fixed price contract with no set-aside designation. The contract work will be performed at Glaxosmithkline's facilities in Research Triangle Park, North Carolina. Glaxosmithkline has provided a range of pharmaceutical products and services to federal agencies, including influenza vaccines, antiviral medications, and COVID-19 treatments.
Quick answers
Who was awarded contract HHSO10033001T?
HHSO10033001T was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 1, 2012.
How much is contract HHSO10033001T worth?
The government has obligated $4,002,243 on HHSO10033001T.
Is contract HHSO10033001T an order under another contract?
Yes. HHSO10033001T is a delivery order under HHSO100201200013I, an indefinite delivery contract, on Pandemic Influenza Preparedness and Response 2012-2016.
Was contract HHSO10033001T competed?
The extent of competition for HHSO10033001T was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award